By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


TcLand Expression 

Halle 13, Bio-Ouest Ile de Nantes
21 Rue de la Noue Bras de Fer
Nantes    44200  France
Phone: 33-2-40-35-89-99 Fax: 33-2-40-35-67-20


Company News
TcLand Expression Will Receive 1.2 Million Euros from Oseo and ERDF to Support a Leading Project in Personalised Medicine Focused on Rheumatoid Arthritis 6/17/2011 8:30:56 AM
TcLand Expression's Board of Directors Appoints Highly Qualified Personalized Medicine Expert Felix Frueh Phd, as New Board Member 4/19/2011 9:23:32 AM
TcLand Expression is Part of the Innovative Medicines Initiative "Be The CURE", the Largest European Consortium for Rheumatology 3/22/2011 9:30:54 AM
TcLand Expression Launches the "PRINT" International Clinical Trial to Validate its Blood Biomarker RA-INF-Dx and Announces the Recruitment of its First Patient 2/22/2011 9:41:01 AM
TcLand Expression Appoints its Scientific and Medical Advisory Board Dedicated to Rheumatology 1/13/2011 10:26:50 AM
TcLand Expression Strengthens Its Senior Management Team by Appointing Peter Payne as Chief Business Officer and Head of US Operations 12/20/2010 11:13:24 AM
TcLand Expression Signs A Licensing Agreement With Inserm Transfert And Initiates A Strategic Collaboration On The Development Of Companion Diagnostic Tests For Rheumatoid Arthritis Therapies 7/7/2010 12:52:40 PM
TcLand Expression And Its Collaborative Partners Receive €450,000 (552,000 USD) In Funding From The French National Research Agency For The Company's Companion Diagnostic Program In Rheumatoid Arthritis. 5/27/2010 11:12:23 AM
TcLand Expression Launches An International, Multicenter Clinical Validation Study 10/13/2009 1:54:09 PM
TcLand Expression, A World Leader In The Field Of Gene Expression Biomarkers In Immunology, Receives €1.8 Million In Innovation Support From Oseo 4/28/2009 1:50:45 PM